Categories AlphaGraphs, Earnings, Health Care
Key highlights from CVS Health (CVS) Q2 2020 earnings results
CVS Health Corporation (NYSE: CVS) reported second quarter 2020 earnings results today.
Total revenues increased 3% to $65.3 billion, driven by growth across all segments.
The COVID-19 pandemic negatively affected results in the Pharmacy Services and Retail/LTC segments as new therapy prescriptions dropped due to lower provider visits.
Net income grew 54.6% to $2.9 billion, or $2.26 per share. Adjusted EPS totaled $2.64.
CVS raised its GAAP EPS guidance range to $5.59-5.72 from $5.47-5.60 and adjusted EPS guidance range to $7.14-7.27 from $7.04-7.17.
Past Performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Micron (MU) projects record Q3 revenue, powered by strong HBM sales
Micron’s (NASDAQ: MU) second-quarter report underscores its leadership position in high-bandwidth memory (HBM) chips and AI-driven data center solutions. The expanding portfolio of high-margin products gives the memory chipmaker a
FedEx (FDX): Uncertain demand environment and inflationary pressures dampen outlook
Shares of FedEx Corp. (NYSE: FDX) were down 6% on Friday after the company reported its earnings results for the third quarter of 2025 and lowered its outlook for the
NKE Earnings: Nike reports lower sales for Q3 2025
NIKE, Inc. (NYSE: NKE) has reported a decline in earnings for the third quarter of 2025, hurt by a slowdown in sales across all major markets and operating segments. The
